Gasmi Mehdi 4
4 · Adverum Biotechnologies, Inc. · Filed Jun 25, 2020
Insider Transaction Report
Form 4
Gasmi Mehdi
VP, Pharmaceutical Development
Transactions
- Award
Stock Option (Right to Buy)
2020-06-23+30,000→ 30,000 totalExercise: $25.64Exp: 2030-06-22→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of June 23, 2021 or the 2021 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date.